Clinical trials
Phase 2 Breast Neoplasms trials in Romania
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
15 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2006 | 2 |
| 2007 | 3 |
| 2009 | 3 |
| 2012 | 1 |
| 2014 | 2 |
| 2015 | 1 |
| 2016 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 11 |
| Terminated | 2 |
| Active, not recruiting | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| GlaxoSmithKline | 2 |
| Hoffmann-La Roche | 2 |
| Puma Biotechnology, Inc. | 2 |
| AbbVie | 1 |
| AstraZeneca | 1 |
| Eli Lilly and Company | 1 |
| Iuliu Hatieganu University of Medicine and Pharmacy | 1 |
| Maxygen Holdings Ltd. | 1 |
| MediGene | 1 |
| Queen Mary University of London | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Breast Neoplasms | 15 |
| Neoplasm Metastasis | 3 |
| Neoplasms | 2 |
| Inflammatory Breast Neoplasms | 1 |
| Neutropenia | 1 |
| Recurrence | 1 |
| Triple Negative Breast Neoplasms | 1 |
Trials
Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.